November 19, 2021

The U.S. FDA has expanded emergency use authorization (EUA) for the Pfizer/BioNTech and Moderna COVID-19 vaccines. They can now be used to administer a booster dose to all U.S. adults who have completed primary vaccination with any FDA-authorized or approved COVID-19 vaccine.

  • Adults who received the Pfizer/BioNTech or Moderna vaccine for primary vaccination can receive a booster dose of either product at least six months after completing primary vaccination.
  • Adults who received the Janssen (Johnson & Johnson) vaccine for primary vaccination can receive a Pfizer/BioNTech or Moderna booster at least two months after receiving the Janssen vaccine.
  • Under the EUA, individuals do not have to receive the same brand of vaccine for their booster dose as they received for their primary vaccination series.
January 3, 2022

FDA Expands Comirnaty Authorization to Prevent COVID-19

Read More
December 23, 2021

Merck’s COVID-19 Antiviral Granted Emergency Use Authorization

Read More
December 22, 2021

FDA Authorizes First Oral Antiviral for COVID-19

Read More
December 20, 2021

Xarelto Approved to Treat and Prevent Blood Clots in Children

Read More